BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer. Onco Targets Ther. 2017;10:4527-4534. [PMID: 28979144 DOI: 10.2147/ott.s142149] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Shukla SP, Zhang H, Fang B, Minna JD, Gomika Udugamasooriya D. Unbiased peptoid cell screen identifies a peptoid targeting newly appeared cell surface vimentin on tumor transformed early lung cancer cells. Bioorganic & Medicinal Chemistry 2022;58:116673. [DOI: 10.1016/j.bmc.2022.116673] [Reference Citation Analysis]
2 Zhang L, Zhu Y, Wei X, Chen X, Li Y, Zhu Y, Xia J, Huang Y, Huang Y, Wang J, Pang Z. Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.005] [Reference Citation Analysis]
3 Misir S, Hepokur C, Aliyazicioglu Y, Enguita FJ. Biomarker potentials of miRNA-associated circRNAs in breast cancer (MCF-7) cells: an in vitro and in silico study. Mol Biol Rep 2021;48:2463-71. [PMID: 33774752 DOI: 10.1007/s11033-021-06281-5] [Reference Citation Analysis]
4 Khan M, Liu S, Qi L, Ma C, Munir S, Yu L, Hu Q. Liquid crystal-based sensors for the detection of biomarkers at the aqueous/LC interface. TrAC Trends in Analytical Chemistry 2021;144:116434. [DOI: 10.1016/j.trac.2021.116434] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Milano A, Mazzetta F, Valente S, Ranieri D, Leone L, Botticelli A, Onesti CE, Lauro S, Raffa S, Torrisi MR, Marchetti P. Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice. Anal Cell Pathol (Amst) 2018;2018:3506874. [PMID: 29682444 DOI: 10.1155/2018/3506874] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
6 Liang H, Huang J, Wang B, Liu Z, He J, Liang W. The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer. J Thorac Dis 2018;10:S838-45. [PMID: 29780630 DOI: 10.21037/jtd.2018.04.08] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
7 Lin T, Fu Y, Zhang X, Gu J, Ma X, Miao R, Xiang X, Niu W, Qu K, Liu C, Wu Q. A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer. Aging (Albany NY) 2018;10:2356-66. [PMID: 30205363 DOI: 10.18632/aging.101550] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
8 Dastidar MG, Murugappan K, Damry AM, Nisbet DR, Nolan CJ, Tricoli A. When Less Gold is More: Selective Attomolar Biosensing at the Nanoscale. Adv Funct Materials. [DOI: 10.1002/adfm.202105433] [Reference Citation Analysis]
9 Verardo D, Liljedahl L, Richter C, Agnarsson B, Axelsson U, Prinz CN, Höök F, Borrebaeck CAK, Linke H. Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding Nanowires. Nanomaterials (Basel) 2021;11:227. [PMID: 33467141 DOI: 10.3390/nano11010227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Huang X, Shu C, Chen L, Yao B. Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer. Oncol Rep 2018;40:1359-69. [PMID: 29956810 DOI: 10.3892/or.2018.6529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
11 Chen YJ, Guo YN, Shi K, Huang HM, Huang SP, Xu WQ, Li ZY, Wei KL, Gan TQ, Chen G. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Respir Res 2019;20:48. [PMID: 30832674 DOI: 10.1186/s12931-019-0994-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
12 Thornblade LW, Mulligan MS, Odem-Davis K, Hwang B, Waworuntu RL, Wolff EM, Kessler L, Wood DE, Farjah F. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer. Ann Thorac Surg 2018;106:1460-7. [PMID: 30031845 DOI: 10.1016/j.athoracsur.2018.06.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang C, Quan Y, Bai Y, Yang L, Yang Y. The effect and apoptosis mechanism of 6-methoxyflavone in HeLa cells. Biomarkers 2022;:1-34. [PMID: 35400257 DOI: 10.1080/1354750X.2022.2062448] [Reference Citation Analysis]
14 Wu W, Wang X, Shan C, Li Y, Li F. Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma. Onco Targets Ther 2018;11:5025-34. [PMID: 30174440 DOI: 10.2147/OTT.S169002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
15 Cheng Y, Hou K, Wang Y, Chen Y, Zheng X, Qi J, Yang B, Tang S, Han X, Shi D, Wang X, Liu Y, Hu X, Che X. Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma. Front Oncol 2021;11:665276. [PMID: 34249701 DOI: 10.3389/fonc.2021.665276] [Reference Citation Analysis]
16 Zhang Y, Roth JA, Yu H, Ye Y, Xie K, Zhao H, Chang DW, Huang M, Li H, Qu J, Wu X. A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer. Carcinogenesis 2019;40:643-50. [PMID: 30428030 DOI: 10.1093/carcin/bgy132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
17 Chen R, Huang M, Yang X, Chen XH, Shi MY, Li ZF, Chen ZN, Wang K. CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells. Front Oncol 2021;11:743050. [PMID: 34660305 DOI: 10.3389/fonc.2021.743050] [Reference Citation Analysis]
18 Zhang C, Jiang M, Zhou N, Hou H, Li T, Yu H, Tan YD, Zhang X. Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer. Sci Rep 2021;11:3596. [PMID: 33580150 DOI: 10.1038/s41598-020-80735-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Terlizzi M, Colarusso C, De Rosa I, De Rosa N, Somma P, Curcio C, Sanduzzi A, Micheli P, Molino A, Saccomanno A, Salvi R, Aquino RP, Pinto A, Sorrentino R. Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer. Oncotarget 2018;9:19356-67. [PMID: 29721208 DOI: 10.18632/oncotarget.25049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kho BG, Park HY, Cho HJ, Park CK, Kim YC, Yun JS, Song SY, Na KJ, Choi YD, Lee SW, Oh IJ. Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery. J Clin Med 2020;9:E3801. [PMID: 33255360 DOI: 10.3390/jcm9123801] [Reference Citation Analysis]
21 Washetine K, Kara-Borni M, Heeke S, Bonnetaud C, Félix JM, Ribeyre L, Bence C, Ilié M, Bordone O, Pedro M, Maitre P, Tanga V, Gormally E, Mossuz P, Lorimier P, Marquette CH, Mouroux J, Cohen C, Lassalle S, Long-Mira E, Clément B, Dagher G, Hofman V, Hofman P. Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA. Cancers (Basel) 2018;10:E195. [PMID: 29891792 DOI: 10.3390/cancers10060195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Zheng H, Zhan Y, Liu S, Lu J, Luo J, Feng J, Fan S. The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications. J Exp Clin Cancer Res. 2018;37:226. [PMID: 30217217 DOI: 10.1186/s13046-018-0901-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
23 Mpilla GB, Philip PA, El-Rayes B, Azmi AS. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations. World J Gastroenterol 2020; 26(28): 4036-4054 [PMID: 32821069 DOI: 10.3748/wjg.v26.i28.4036] [Reference Citation Analysis]
24 Peng Z, Duan F, Yin J, Feng Y, Yang Z, Shang J. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test. J Transl Med 2019;17:347. [PMID: 31640738 DOI: 10.1186/s12967-019-2093-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 de Assumpção PP, Khayat AS, Thomaz Araújo TM, Barra WF, Ishak G, Cruz Ramos AMP, Dos Santos SEB, Dos Santos ÂKCR, Demachki S, de Assumpção PB, Calcagno DQ, Dos Santos NPC, de Assumpção MB, Moreira FC, Dos Santos AMR, de Assumpção CB, Riggins GJ, Rodríguez Burbano RM. Traps and trumps from adjacent-to-tumor samples in gastric cancer research. Chin J Cancer Res 2018;30:564-7. [PMID: 30510368 DOI: 10.21147/j.issn.1000-9604.2018.05.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Lee JE. How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis. Osong Public Health Res Perspect 2018;9:105-11. [PMID: 30023154 DOI: 10.24171/j.phrp.2018.9.3.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
27 Yu Y, Ren K. Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer. BMC Cancer 2021;21:457. [PMID: 33892664 DOI: 10.1186/s12885-021-08207-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Guzman NA, Guzman DE. Immunoaffinity Capillary Electrophoresis in the Era of Proteoforms, Liquid Biopsy and Preventive Medicine: A Potential Impact in the Diagnosis and Monitoring of Disease Progression. Biomolecules 2021;11:1443. [PMID: 34680076 DOI: 10.3390/biom11101443] [Reference Citation Analysis]
29 Tao R, Cao W, Zhu F, Nie J, Wang H, Wang L, Liu P, Chen H, Hong B, Zhao D. Liquid biopsies to distinguish malignant from benign pulmonary nodules. Thorac Cancer 2021;12:1647-55. [PMID: 33960710 DOI: 10.1111/1759-7714.13982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]